Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00199875Phase 1Completed
Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250
Kidney CancerKidney NeoplasmRenal Cancer+1 more
PrincipalinvestigatorStart date: 2005-07-06

Research Network

Collaboration Network

4 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Memorial Sloan Kettering Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Neeta Pandit-Taskar, MD

Memorial Sloan Kettering Cancer Center

Moderately Similar
8 trials

Shared therapeutic areas:

Cancer of KidneyKidney NeoplasmsCarcinoma, Renal Cell

Worked with same sponsors:

Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center
Collaborated on 1 trial
Similarity Score34%

Robert Motzer, MD

Memorial Sloan Kettering Cancer Center

Moderately Similar
2 trials

Shared therapeutic areas:

Cancer of KidneyKidney NeoplasmsCarcinoma, Renal Cell

Worked with same sponsors:

Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center
Collaborated on 1 trial
Similarity Score34%

Steven Larson, MD

Memorial Sloan Kettering Cancer Center

Moderately Similar
2 trials

Shared therapeutic areas:

Cancer of KidneyKidney NeoplasmsCarcinoma, Renal Cell

Worked with same sponsors:

Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center
Collaborated on 1 trial
Similarity Score34%

Dr. Sandy Srinivas

Stanford University

Moderately Similar
11 trials

Shared therapeutic areas:

Kidney NeoplasmsCarcinoma, Renal CellCancer of Kidney
Similarity Score30%

Eric Jonasch, MD

M.D. Anderson Cancer Center

Related
14 trials

Shared therapeutic areas:

Carcinoma, Renal CellCancer of Kidney
Similarity Score20%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Carcinoma, Renal CellCancer of Kidney
Similarity Score20%

Scot C. Remick, MD

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

Related
13 trials

Shared therapeutic areas:

Cancer of Kidney
Similarity Score10%

Gustavo Leone

Medical University of South Carolina, Hollings Cancer Center

Related
12 trials

Shared therapeutic areas:

Cancer of Kidney
Similarity Score10%

Jane Robertson

AstraZeneca

Related
10 trials

Shared therapeutic areas:

Carcinoma, Renal Cell
Similarity Score10%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Cancer of Kidney
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00199875Phase 1PrincipalInvestigator

Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250

Kidney CancerKidney NeoplasmRenal Cancer+1 more
Completed

All 1 trials loaded